Clinical Trial Update: A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This is a Phase II randomized trial comparing trastuzumab with ixabepilone versus trastuzumab with docetaxel in patients with metastatic breast cancer; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Ixabepilone (ixabepilone)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: R-Pharm | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-07-18